117th Congress · HOUSE BILLBILL

H.R. 4991 — Affordable Pricing for Taxpayer-Funded Prescription Drugs Act of 2021

“To require persons who undertake federally funded research and development of a biomedical product or service to enter into reasonable pricing agreements with the Secretary of Health and Human Services, and for other purposes.”

Health

Introduced Aug 10, 2021

Last action Aug 11, 2021

Pipeline · Bill → Law

Step 1

Introduced

Aug 10, 2021

Step 2

Referred

Aug 11, 2021

E&C

Step 3

Committee

Step 4

House floor

Step 5

Senate

Step 6

Resolve Changes

Step 7

Signed

SummaryNo summary available

No CRS summary available for this bill.

Provisions · 2 sectionsIntroduced in House

Timeline · 3 actions

Aug 11, 2021

Referred to the Subcommittee on Health.

Aug 10, 2021

Introduced in House

Aug 10, 2021

Referred to the House Committee on Energy and Commerce.